TradingMarkets’ 5 Stocks You Need To Know About This Morning
Accredo Health
(
ACDO |
Quote |
Chart |
News |
PowerRating) slashed its 2004
forecast.
Wal Mart
(
WMT |
Quote |
Chart |
News |
PowerRating) may buy UK retailer
Matalan for $1.8 billion.
Tyson
(
TSN |
Quote |
Chart |
News |
PowerRating) lowered 2004 guidance, citing
higher costs and weaker chicken demand.
An FDA committee put off a vote on Eyetech’s
(
EYET |
Quote |
Chart |
News |
PowerRating) Macugen. The FDA did make some positive comments, however. The stock
was halted most of the day Friday.
QLT [
(
QLTI |
Quote |
Chart |
News |
PowerRating), a competitor of Eyetech,
lost ground pre-open.
In Barron’s this weekend: American Science &
Engineering
(
ASE |
Quote |
Chart |
News |
PowerRating), which was thought to de well in an anti-terror
envoronment; Drexler Technology
(
DRXR |
Quote |
Chart |
News |
PowerRating), OSI Systems
(
OSIS |
Quote |
Chart |
News |
PowerRating)
(x-ray screening), and Vical
(
VICL |
Quote |
Chart |
News |
PowerRating) (anthrax vaccine), Dentsply
(
XRAY |
Quote |
Chart |
News |
PowerRating) (baby boomers need more dental care), Lojack
(
LOJN |
Quote |
Chart |
News |
PowerRating) (unit sales
+16% in 2004).